The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.

Area of Science:

• Psychiatry
• Clinical Pharmacology
• Neuroscience

Background:

• Early response to antipsychotics predicts psychiatric outcomes.
• The relationship between early response and extrapyramidal side effects (EPSs) is not well understood.

Purpose of the Study:

• To investigate if early response to antipsychotic treatment predicts the incidence of EPSs.
• To determine if early response predicts EPSs in patients who initially showed no side effects.

Main Methods:

• 136 antipsychotic-naive, first-episode psychosis patients treated with haloperidol.
• Weekly assessments using Brief Psychiatric Rating Scale, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, and EPS rating scales.
• Regression analyses to assess the predictive value of week 2 response on EPS incidence.

Main Results:

• Greater improvement on the Brief Psychiatric Rating Scale at week 2 predicted a decreased risk of EPSs (P = 0.004).
• This prediction remained significant even in patients without early EPS (P = 0.005).
• Early response predicted decreased parkinsonism and dyskinesia, but not akathisia or dystonia.

Conclusions:

• Early antipsychotic response is a valuable predictor of both psychiatric outcomes and the risk of developing EPSs.
• Assessing early response can help anticipate and potentially mitigate the risk of side effects.